Global Medical Nutrition industry sales reached approximately USD 16,192.6 million at the end of 2024. Forecasts suggest the market will achieve a 6.4% compound annual growth rate (CAGR) and exceed USD 26,555.9 million in value by 2034
Rising awareness about the role of medical nutrition in disease management and prevention is one of the drivers for the medical nutrition market. Countries such as China, and Japan have seen a rise in the number of elderly persons and this has been accompanied by an increase in diseases such as diabetes, cardiovascular diseases, cancer, and gastrointestinal disorders among others which often require specialized nutritional support. Manufacturers are coming up with medical products to provide complete nutrition solutions.
For example, Abbott’s Ensure range of products has become instrumental in providing a comprehensive and balanced diet to aged patients as well as those recovering from ailments by having solutions that are aimed at their dietary needs specifically.
They boost immunity, improve muscle strength, and promote overall healing all addressing major health concerns leading to better patient outcomes. Personalized dietary plans based on individual health profiles as well as genetic predispositions have become possible due to technological innovations in medical nutrition.
For instance, companies like Nestle Health Science have utilized these developments to design customized nutritional therapies focusing on malnutrition in hospitalized patients. Such products include Peptamen for enteral nutrition support that are easily absorbed and tolerated thus supplying essential nutrients to patients who cannot take enough food through the mouth.
This level of precision and customization ultimately leads to increased patient compliance while also highlighting the direction in which effective healthcare solutions need to go, i.e., toward more enhanced and patient-focused healthcare services.
| Attributes | Description |
|---|---|
| Estimated Global Medical Nutrition Size (2024E) | USD 16,192.6 Million |
| Projected Global Medical Nutrition Value (2034F) | USD 26,555.9 Million |
| Value-based CAGR (2024 to 2034) | 6.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing demand for nutritional support for the infant population
A rising awareness of the significance of Paediatric medical nutrition on long-term health drives up the request for baby food for nutritional support. Some company such as Nestle Health Science have also come up with new products tailored to these needs.
Nestle’s Meritene Baby, for example, constitutes a special selection of medical nutrition that addresses cognitive development and immune system development, among others while ensuring that the young ones are well-nourished. Such nutrients comprise vitamins, minerals, and essential fats which help in promoting healthy growth in infants.
The focus remains on delivering safe, effective, and developmental-supportive infant nutrition even as companies continue innovating and expanding their product ranges
Growing diagnoses of gastrointestinal disorders such as IBD and celiac disease driving the medical nutrition industry
In the medical nutrition market, gastrointestinal disorders are on the rise and this includes celiac disease and inflammatory bowel disease (IBD) as well. The number of diagnoses keeps increasing therefore making it necessary for dietary interventions that address the particular requirements of these people.
For example, products such as Nutricia by Danone which is formulated for patients with conditions like IBD. To help patients manage their symptoms and improve their quality of life through scientifically backed formulations and advancing research into diet’s role in disease management, these products are developed to provide directed nutritional support.
It is a confirmation that the market is focusing on developing efficient nutritional treatments for patients with gut illnesses other than just traditional dietary changes alone.
Growing adoption of medical nutrition in developing countries such as India.
In India, the growing use of medicinal diets is influenced by several factors that contribute to enhanced medical services access, surging prevalence of chronic diseases, and rising consciousness about nutrition as it pertains to health care. Diseases like diabetes, cardiovascular conditions, and obesity are increasing. This change in population structure has increased the demand for nutrition interventions that aid in the prevention and management of diseases thus resulting in greater acceptance of medical nutritional products.
One such initiative is the National Nutrition Mission (NNM) or Poshan Abhiyaan aimed at promoting healthcare infrastructure and public health awareness by the Indian Government. For instance, Poshan Abhiyaan is designed to comprehensively miti gate malnutrition across India by targeting maternal and child nourishment.
To improve nutritional outcomes through targeted interventions, public awareness campaigns, and capacity building at the grassroots level, the mission integrates various existing programs and initiatives under one umbrella.
Global Medical Nutrition increased at a CAGR of 5.1% from 2019 to 2023. For the next ten years (2024 to 2034), projections are that expenditure on medical nutrition will rise at 6.4% CAGR
In this period, 2019-2023, the market experienced an increasing demand for specialized nutritional products targeting conditions like malnutrition, diabetes, gastrointestinal disorders, and nutrition requirements associated with oncology. To this end, firms sought to create an expanded line of products that catered to diverse demographic groups and diseases.
Besides that, the growth of personal medicine and digital health where a technology for healthcare was on the rise led to further market expansion hence improving the effectiveness as well as precision in dealing with nutrition.
From 2024 through 2034 medical nutrition product market is expected to continue to grow at a significant rate. The major drivers include a globally aging population prone to chronic diseases necessitating nutritional support and ongoing medical research advancements that point out the importance of diet in disease prevention and control.
Emerging markets such as those in Asia-Pacific and Latin America are anticipated to witness higher adoption of medical nutrition due to improvements in healthcare infrastructure and rising disposable incomes.
Principal Consultant
The global medical nutrition industry is dominated by many big players, namely Zeon Lifesciences Ltd., DSM, Abbott, Danone S.A, Baxter, Nestle, GSk plc, Sun Pharmaceutical Industries Ltd, and many more. These business leaders constitute a significant value share.
These brands have extensive good manufacturing practices and distinguish themselves from the competitors by an elaborate distribution network and regional presence. Their products are widely present at retail stores present worldwide. They offer a wide product portfolio accompanied by modern packaging formats. They concentrate on meeting the regulatory standards to garner more consumer trust and build brand loyalty.
Regional brands have a distinct advantage in their ability to cater to local consumers' specific needs and preferences. While they may lack the resources for extensive research and development compared to national brands, regional players make up for it with their deep understanding of the local market and strong connections with their target consumers.
Regional brands adapt quickly to changing market conditions and consumer trends due to their agility and proximity to the local market.
The table below highlights revenue from product sales in key countries. The United States and Germany are predicted to remain top consumers, with estimated valuations of USD 6,506.2 Million and USD 4,912.8 Million, respectively, by 2034.
| Countries | Value (2034) |
|---|---|
| United States | USD 6,506.2 Million |
| Germany | USD 4,912.8 Million |
| Japan | USD 2,018.2 Million |
| China | USD 4,381.7 Million |
| India | USD 3,638.2 Million |
The following table shows the estimated growth rates of the top three industries. China and India are set to exhibit high Medical Nutrition consumption, recording CAGRs of 6.5% and 9.2%, respectively, through 2034.
| Countries | CAGR 2024 to 2034 |
|---|---|
| United States | 4.3% |
| Germany | 5.1% |
| Japan | 7.6% |
| China | 6.5% |
| India | 9.2% |
The sale of medical nutrition in the United States is projected to exhibit a CAGR of 4.3% during the assessment period by 2034, and revenue from the sales of Medical Nutrition in the country is expected to reach USD 6,506.2 million
Significant investments and advances in nutritional sciences make the United States a leader in healthcare R&D. This leadership ensures continuous innovation and development of up-to-date medical nutrition products capable of being tailored to special health conditions and patient demographics.
As exemplified by Abbott Nutrition and Nestle Health Science among others, they have research institutions and academic collaborations within the territory that allow them to introduce new formulations and provide evidence-based nutrition solutions.
Product safety, efficacy, and quality control are extremely strict under the US regulatory framework. The FDA is responsible for approving and regulating medical nutrition products thereby giving assurance to both medical practitioners and consumers. These factors in addition to high consumer demand for health & wellness products have contributed collectively to sustain America’s worldwide dominance on the global sales market of medical nutrition.
Medical Nutrition demand in Germany is expected to rise at a value CAGR of 5.1% during the forecast period 2024 to 2034. By 2034, Germany is expected value share to account for 21.5% of medical nutrition sales in Europe.
In Germany, the availability and effectiveness of medical nutrition products have been changed by technological advances in healthcare and the incorporation of digital health solutions.
Popular remote consultation choices such as Fernarzt and Zava are helping professionals make custom nutritional counseling and dietary recommendations from where they reside. These services depend on secure communication channels and digital tools that guarantee patient privacy while improving access to healthcare.
Similarly, individuals are making use of digital health apps such as MyFitnessPal as well as food-tracking applications that are recommended by their physicians for better monitoring of their diets.
These apps provide instant feedback on dietary patterns thereby allowing users to make informed decisions regarding their nutrition health objectives. In addition, these advancements aim at enhancing patients' involvement while enabling them to comply with prescribed diet plans hence leading to increased efficiency in medical nutritional therapy.
The future of medical nutrition in Germany may be determined largely by companies that invest in telehealth systems with healthcare providers and employ digital health technologies.
Consumption of Medical Nutrition in China is expected to increase at a value CAGR of 6.5% over the next ten years. By 2034, the sale size is forecasted to reach USD 4,381.7 Million, with Japan expected to account for a market share of 48.1% in East Asia.
In China, the demand for medical nutrition products is soaring because of several catalysts such as income changes, premium specialized infant formulas that meet particular dietary requirements and well-being concerns are becoming increasingly popular among Chinese consumers.
Mead Johnson Nutrition, now owned by Reckitt Benckiser Group, and others have since introduced products aimed at promoting brain growth in infants in addition to enhancing their immunity and digestion as preferred by Chinese parents today
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | Multivitamins & Antioxidant (Nutrition Type) |
|---|---|
| Value Share (2024) | 28.5% |
Sales of multivitamins and antioxidants are projected to register a CAGR of 6.7% from 2024 to 2034.
The medical nutrition sector needs multivitamins and antioxidants because they play a key role in upholding general health and mitigating diverse diseases. People embrace dietary supplementations as they are convenient in enhancing their daily consumption of vitamins and minerals, particularly when dieting may be insufficient and some medical conditions require more nourishment.
As a leading provider of nutritional ingredients worldwide, DSM offers various types of multivitamin products in combination with antioxidants that are extensively utilized in the field of medical nutrition.
| Segment | Oral (Mode of Delivery) |
|---|---|
| Value Share (2024) | 32.2% |
The rapidly growing popularity of the oral mode of delivery segment is anticipated to advance at 9.5% CAGR during the projection period.
Advancements in formulation technology have improved the taste, texture, and bioavailability of medical nutrition thereby increasing the popularity of oral mode of delivery.
For instance, Ensure is a commonly known brand for adult oral nutritionals offered in different types such as Ensure Original, Ensure Plus, and Ensure Enlive which are tailored to meet individuals’ various health conditions. These products have been manufactured by considering cases like poor nourishment due to sickness, wounds, and old age.
Conversely, PediaSure is a range of children’s oral liquid nutritional made for kids who might be having problems with growth or may be lacking some nutrients in their diet. The product helps in providing vital nutrients necessary for normal growth and development thus assisting parents to ensure that their children get enough dietary requirements.
This technique uses an oral route provides meet the nutritional needs of diverse patient populations and has several other reasons why customers prefer them among key players in the medical nutrition market.
| Segment | Store Base (Sales Channel) |
|---|---|
| Value Share (2024) | 36% |
Sales of medical nutrition store base sales channel are projected to register a CAGR of 7.3% from 2024 to 2034.
Among various sales channels, store-based retailing, in particular through pharmacies and drug stores has been a popular one for medical nutrition due to the health experts’ guidance offered by these outlets.
Pharmacists and other healthcare professionals must guide patients on medical nutritional product use and selection. They are highly qualified which means customers get tailored advice depending on their physical well-being such as managing diabetes or recovering from surgery
Several consumers trust these firms when it comes to purchasing medical nutrition owing to their past credible reputation for quality and product reliability. The available brands within these retail stores are normally those known to meet standards set by regulating bodies thus making sure that the products they offer are both safe and efficient
One example is CVS Pharmacy in the United States also provides a pharmacy advisor - if the person needs calcium supplement for bone support, then a CVS Pharmacy pharmacist would tell him/her about different forms of supplements available, suggest doses according to the patient’s age and other health conditions, as well as give better times of taking it to enhance absorption.
There are numerous key players in the industry. This is a significant point, but no one big player is dominating the market. Market leaders have been focusing on scaling up their production and supply chains to reach out to more consumers. The customers’ want is what is pushing them into such partnerships and alliances (Czinki et al., 2018).
Apart from this, they are also diversifying their product range through different formats and selling via various sales channels.
For example:
In 2022, a partnership between Danone and Bioiberica was established to develop and commercialize nutritional solutions for musculoskeletal health, specifically osteoarthritis. The deal allows Bioiberica to leverage its extensive clinical expertise while Danone could bring its scientific know-how and other competencies to provide proper medical nutrition solutions that meet the needs of patients suffering from movement-related problems associated with aging populations
As per By Nutrition Type, the segment has been categorized into Proteins, Carbohydrates, Multivitamins & Antioxidant, Amino acids, Fiber, Mineral and others.
Health Conditions included Cancer, Diebties, Gastrointestinal disease, metabolic syndrome, and others
This segment is further categorized into infant, adult, and Geriatric
The modes of delivery include Oral, Enteral, and Parenteral
Different Sales channels include Store-based Retailing, (Hypermarkets & Supermarkets, Convenience Store, Drug Stores & Pharmacies, Specialty Stores, and Other Retailers) and Online Retailing
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.
The global medical nutrition sale is estimated at a value of USD 16,192.6 Million in 2024.
Zeon Lifesciences Ltd, DSM, Abbott, Danone S.A, Baxter, Nestle, and other manufacturers in medical nutrition.
The North American sector is projected to hold a revenue share of 27.5% over the forecast period.
Europe holds a 23.8% share of the global industry for medical nutrition.
1. Executive Summary 2. Industry Introduction, Including Taxonomy and Market Definition 3. Market Trends and Success Factors, Including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Nutrition Type 6.2. Health Condition 6.3. Patient Type 6.4. Mode of Delivery 6.5. Sales Channel 6.6. Region 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Nutrition Type 7.1. Proteins 7.2. Carbohydrates 7.3. Multivitamins & Antioxidant 7.4. Amino acid 7.5. Fiber 7.6. Mineral 7.7. Others 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Health Condition 8.1. Cancer 8.2. Diabetes 8.3. Gastrointestinal Disease 8.4. Metabolic Syndrome 8.5. Others 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Patient Type 9.1. Infant 9.2. Adult 9.3. Geriatric 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Mode of Delivery 10.1. Oral 10.2. Enteral 10.3. Parenteral 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Sales Channel 11.1. Store-based Retailing 11.1.1. Hypermarkets & Supermarkets 11.1.2. Convenience Store 11.1.3. Drug Stores & Pharmacies 11.1.4. Specialty Stores 11.1.5. Other Retailers 11.2. Online Retailing 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 12.1. North America 12.2. Latin America 12.3. Western Europe 12.4. Eastern Europe 12.5. East Asia 12.6. South Asia and Pacific 12.7. Middle East and Africa 13. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 19. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 20. Sales Forecast 2024 to 2034 by Nutrition Type, Health Condition, Patient Type, Mode of Delivery, and Sales Channel for 30 Countries 21. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 22. Company Profile 22.1. Zeon Lifesciences Ltd. 22.2. DSM 22.3. Abbott 22.4. Danone S.A. 22.5. Baxter 22.6. Nestle 22.7. GSK plc 22.8. Sun Pharmaceutical Industries Ltd. 22.9. Sanofi 22.10. BASF SE 22.11. Fresenius SE & Co. 22.12. KGaA 22.13. Leprino Foods Company 22.14. Fresenius Kabi Ltd. 22.15. Esperer Onco Nutrition 22.16. Kate Farms 22.17. Guardion Health Sciences
Explore Food and Beverage Insights
View Reports
Medical Nutrition Market
